MOORESTOWN, N.J., (March 26, 2020) – Tabula Rasa HealthCare®, Inc. (“TRHC”) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, has named Frank Sparacino Senior Vice President of Investor Relations and Corporate Development. Sparacino will be responsible for overseeing TRHC’s interactions with the investment community and formalizing a corporate development function. “Frank is the ideal candidate to take on this important new role with Tabula Rasa HealthCare. He is a former sell... Read More
Moorestown, NJ – March 24, 2020 – Tabula Rasa HealthCare®, Inc. (TRHC) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, is coordinating an effort to help Programs of All-Inclusive Care for the Elderly (PACE) with access to COVID-19 (SARS-CoV-2 RNA) testing kits. The testing kits are being made available through TRHC’s PACE pharmacy, CareKinesis®. “We are committed to the wellness and safety of the participants we serve in PACE and of... Read More
Moorestown, NJ (March 19, 2020) Tabula Rasa HealthCare, Inc. (“TRHC”) (NASDAQ: TRHC). 2020 Women on Boards, the premier global education and advocacy campaign committed to increasing the number of women on corporate boards, has recognized TRHC as a Winning “W” company, because its 2019 corporate board had at least 20% women directors. TRHC has five female directors out of nine total board members, 55% of its corporate board seats. 2020 Women on Boards (2020WOB) annually... Read More
Moorestown, NJ – March 17, 2020 – Tabula Rasa HealthCare®, Inc. (TRHC) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, enters into an agreement with BioIntelliSense to distribute its BioSticker™, the first FDA-cleared, single-use device enabling 30 days of continuous vital sign monitoring. The BioIntelliSense DaaS platform can be applied to a wide range of clinical use cases, including monitoring for the key symptoms associated with COVID-19 . “BioSticker remote monitoring... Read More
MOORESTOWN, NJ, February 27, 2020 — Tabula Rasa HealthCare, Inc. (“TRHC”) (NASDAQ:TRHC), a healthcare technology company advancing the field of medication safety, today announced its financial results for the fourth quarter and full year ended December 31, 2019. Full Year 2019 Highlights • Total revenue increased 39% to $284.7 million; • Non-GAAP Adjusted EBITDA increased 29% to $37.9 million; • Non-GAAP Adjusted diluted EPS increased to $0.79 from $0.77; • Product revenue increased 22% to... Read More
The January/February issue of Computer Talk for the Pharmacist, featured TRHC’s MedWise technology and PrescribeWellness as a solution for pharmacies to elevate patient care.
Moorestown, NJ, February 18, 2020 –Tabula Rasa HealthCare Corporation®(NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, announced an agreement with a newly established Program for All-inclusive Care of the Elderly (PACE) in Jacksonville, Florida. Known as PACE Place, the program is sponsored by Community Hospice &Palliative Care®. “We’re very excited to collaborate with TRHC for products and services that support high-quality care delivery,” said Executive Director of PACE Place, Mary Kiefert.... Read More
The APhA Foundation announced last month that it would join forces with The Kroger Company and Tabula Rasa HealthCare to add connected health elements to its CDC-approved National Diabetes Prevention Program, called Project IMPACT: Diabetes Prevention. The program, unveiled in 2017, aims to push health and wellness resources and coaching to at-risk populations across the country through pharmacies serving those populations. Read more in mHealthIntelligence.
On Tuesday, January 28, 2020, TD Ameritrade Network’s Opening Bell Show featured Tabula Rasa HealthCare Chairman and CEO Calvin H. Knowlton, PhD.
Moorestown, NJ – February 3, 2020 – Tabula Rasa HealthCare, Inc. (TRHC) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, announces today it will become an Executive Member of the Get the Medications Right Institute™ (GTMRx). GTMRx defines itself as “a catalyst for change that brings critical stakeholders together, bound by the urgent need to get the medications right.” The Institute’s goal is to ensure appropriate and personalized use of medication... Read More